AePONA provided the software engine that powers the “Network as a Service” (NaaS) business model for mobile operators.

Igenomix
Igenomix is a reproductive genetics company providing advanced diagnostic testing to improve fertility outcomes and support women’s health globally. It was acquired by EQT in 2019.
About
Igenomix is a global leader in reproductive genetic services, advancing women’s health and fertility care through cutting-edge genetic testing and research. Founded in 2011 as a spin-out from the Instituto Valenciano de Infertilidad (IVI), the company quickly became a trusted partner to fertility clinics and healthcare professionals worldwide.
It offers a comprehensive portfolio of genetic diagnostic services aimed at improving reproductive outcomes, including preimplantation genetic testing, carrier screening, and personalised fertility assessments. With a strong foundation in scientific innovation and clinical collaboration, Igenomix has played a pivotal role in increasing the success rates of assisted reproductive technologies and providing patients with deeper insight into their reproductive health.
In 2019, the company was acquired by EQT, a global private equity firm, to support its continued growth and expansion across the women’s health and fertility sectors.
